175 related articles for article (PubMed ID: 20399198)
1. The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.
Rocca CJ; Poindessous V; Soares DG; Ouadrani KE; Sarasin A; Guérin E; de Gramont A; Henriques JA; Escargueil AE; Larsen AK
Biochem Pharmacol; 2010 Aug; 80(3):335-43. PubMed ID: 20399198
[TBL] [Abstract][Full Text] [Related]
2. BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder.
Rocca CJ; Soares DG; Bouzid H; Henriques JA; Larsen AK; Escargueil AE
Cell Cycle; 2015; 14(13):2080-90. PubMed ID: 25945522
[TBL] [Abstract][Full Text] [Related]
3. Covalent binding to glutathione of the DNA-alkylating antitumor agent, S23906-1.
David-Cordonnier MH; Laine W; Joubert A; Tardy C; Goossens JF; Kouach M; Briand G; Thi Mai HD; Michel S; Tillequin F; Koch M; Leonce S; Pierre A; Bailly C
Eur J Biochem; 2003 Jul; 270(13):2848-59. PubMed ID: 12823555
[TBL] [Abstract][Full Text] [Related]
4. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
5. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent.
Zewail-Foote M; Li VS; Kohn H; Bearss D; Guzman M; Hurley LH
Chem Biol; 2001 Nov; 8(11):1033-49. PubMed ID: 11731295
[TBL] [Abstract][Full Text] [Related]
6. DMBA-induced toxic and mutagenic responses vary dramatically between NER-deficient Xpa, Xpc and Csb mice.
Wijnhoven SW; Kool HJ; Mullenders LH; Slater R; van Zeeland AA; Vrieling H
Carcinogenesis; 2001 Jul; 22(7):1099-106. PubMed ID: 11408355
[TBL] [Abstract][Full Text] [Related]
7. The knock-down of ERCC1 but not of XPF causes multinucleation.
Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S
DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691
[TBL] [Abstract][Full Text] [Related]
8. Differential ultraviolet-B-induced immunomodulation in XPA, XPC, and CSB DNA repair-deficient mice.
Boonstra A; van Oudenaren A; Baert M; van Steeg H; Leenen PJ; van der Horst GT; Hoeijmakers JH; Savelkoul HF; Garssen J
J Invest Dermatol; 2001 Jul; 117(1):141-6. PubMed ID: 11442761
[TBL] [Abstract][Full Text] [Related]
9. The cross talk between pathways in the repair of 8-oxo-7,8-dihydroguanine in mouse and human cells.
Parlanti E; D'Errico M; Degan P; Calcagnile A; Zijno A; van der Pluijm I; van der Horst GT; Biard DS; Dogliotti E
Free Radic Biol Med; 2012 Dec; 53(11):2171-7. PubMed ID: 23010470
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
Jiang H; Yang LY
Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
12. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
[TBL] [Abstract][Full Text] [Related]
13. Generation of replication-dependent double-strand breaks by the novel N2-G-alkylator S23906-1.
Léonce S; Kraus-Berthier L; Golsteyn RM; David-Cordonnier MH; Tardy C; Lansiaux A; Poindessous V; Larsen AK; Pierré A
Cancer Res; 2006 Jul; 66(14):7203-10. PubMed ID: 16849567
[TBL] [Abstract][Full Text] [Related]
14. Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.
Wang Y; Liu X; Matsuda A; Plunkett W
Cancer Res; 2008 May; 68(10):3881-9. PubMed ID: 18483273
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.
Evans E; Moggs JG; Hwang JR; Egly JM; Wood RD
EMBO J; 1997 Nov; 16(21):6559-73. PubMed ID: 9351836
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
Fautrel A; Andrieux L; Musso O; Boudjema K; Guillouzo A; Langouët S
J Hepatol; 2005 Aug; 43(2):288-93. PubMed ID: 15922480
[TBL] [Abstract][Full Text] [Related]
17. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
Koeppel F; Poindessous V; Lazar V; Raymond E; Sarasin A; Larsen AK
Clin Cancer Res; 2004 Aug; 10(16):5604-13. PubMed ID: 15328203
[TBL] [Abstract][Full Text] [Related]
18. The role of glutathione in the regulation of nucleotide excision repair during oxidative stress.
Langie SA; Knaapen AM; Houben JM; van Kempen FC; de Hoon JP; Gottschalk RW; Godschalk RW; van Schooten FJ
Toxicol Lett; 2007 Feb; 168(3):302-9. PubMed ID: 17207589
[TBL] [Abstract][Full Text] [Related]
19. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
[TBL] [Abstract][Full Text] [Related]
20. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]